MedPath

Onconix Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer

Conditions
Cervical Intraepithelial Neoplasia III
Cervical Cancer
Cervical Intraepithelial Neoplasia II
First Posted Date
2011-06-13
Last Posted Date
2011-06-13
Lead Sponsor
Onconix, Inc
Target Recruit Count
60
Registration Number
NCT01371695
Locations
🇺🇸

Georgia Health Sciences, Augusta, Georgia, United States

© Copyright 2025. All Rights Reserved by MedPath